Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2021 Oct 17;28(1):32.e1–32.e10. doi: 10.1016/j.jtct.2021.10.010

Figure 2 –

Figure 2 –

T cell subsets – (A) CD4+ T cells, (B) CD8+ T cells, (C) Tregs, (D) CD4 T con, (E) Treg:Tcon, (F) Treg:CD8 (pembrolizumab vs control cohort). The interquartile range of healthy control patients for each cell population is depicted as a gray bar, and the median value is noted with a dashed line.